Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|December 5, 2009
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talkSandra Donnini, Erika Terzuoli, Marina Ziche, et al.
Molecular Nutrition & Food Research|November 19, 2015
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradationErika Terzuoli, Antonio Giachetti, Marina Ziche, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistanceValerio Ciccone, Lucia Morbidelli, Marina Ziche, et al.
Critical Reviews in Oncogenesis|February 13, 2018
Nitric Oxide and PGE-2 Cross-Talk in EGFR-Driven Epithelial Tumor CellsSandra Donnini, Lorenzo Bazzani, Marina Ziche, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems StudiesValerio Ciccone, Marina Ziche, Andrea Spini, et al.
Biomedicines|January 18, 2020
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in AgeingGinevra Nannelli, Marina Ziche, Sandra Donnini, et al.
Pharmacological Research|June 7, 2020
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulationMarco Carli, Sandra Donnini, Carolina Pellegrini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatinLucia Morbidelli, Sandra Donnini, Francesco Chillemi, et al.
Pageof 9